A randomised, open-label phase II trial of afatinib versus cetuximab in patients with metastatic colorectal cancer
Authors: Hickish, T., Cassidy, J., Propper, D., Chaud, I., Falke, S., Ford, H., Iveson, T., Braun, M., Potter, V., Macpherson, I., Finnigan, H., Leek, C., Jones, H., Harrison, M.
Journal: European Journal of Cancer
Volume: 50
Source: Manual
Preferred by: Tamas Hickish